Logo Logo
Hilfe
Hilfe
Switch Language to English

Berclaz, Luc M. ORCID logoORCID: https://orcid.org/0000-0003-4405-138X; Di Gioia, Dorit; Jurinovic, Vindi ORCID logoORCID: https://orcid.org/0009-0004-9087-0575; Völkl, Michael; Güler, Sinan ORCID logoORCID: https://orcid.org/0009-0004-6645-9962; Albertsmeier, Markus ORCID logoORCID: https://orcid.org/0000-0002-5028-5062; Klein, Alexander ORCID logoORCID: https://orcid.org/0000-0002-5562-9872; Dürr, Hans Roland ORCID logoORCID: https://orcid.org/0000-0002-1347-1173; Mansoorian, Sina; Knösel, Thomas ORCID logoORCID: https://orcid.org/0000-0002-1822-0197; Kunz, Wolfgang G. ORCID logoORCID: https://orcid.org/0000-0002-5021-1952; Bergwelt-Baildon, Michael von ORCID logoORCID: https://orcid.org/0000-0002-1952-052X; Lindner, Lars H. ORCID logoORCID: https://orcid.org/0000-0003-3708-8264 und Burkhard-Meier, Anton ORCID logoORCID: https://orcid.org/0009-0002-9801-3530 (2025): LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment. In: BMC Cancer, Bd. 25, Nr. 1, 496 [PDF, 1MB]

Abstract

Background: The current understanding of the prognostic value of routine pre-treatment laboratory parameters in patients with high-risk soft tissue sarcoma (HR-STS) is limited. We sought to analyze several inflammatory biomarkers in a large cohort of HR-STS patients undergoing neoadjuvant therapy followed by curative surgical resection.

Methods: 123 patients with locally advanced high-risk undifferentiated pleomorphic sarcoma (UPS), liposarcoma (LPS), leiomyosarcoma (LMS), and synovial sarcoma (SS) who underwent preoperative chemotherapy and regional hyperthermia (RHT) between 2014 and 2022 were retrospectively evaluated. The association of several pre-treatment laboratory parameters with radiologic treatment response, event-free survival (EFS), and overall survival (OS), were analyzed.

Results: Low pre-treatment hemoglobin (HR 2.51, p = 0.018; HR 2.78, p = 0.030) and lactate dehydrogenase (LDH, HR 0.29, p = 0.0044; HR 0.23, p = 0.010) were significantly associated with EFS and OS in the multivariable analysis. Systemic inflammatory indices such as the neutrophil-to-lymphocyte ratio (NLR) did not have a significant impact on survival. Low C-reactive protein (CRP) and high albumin values were associated with poor radiologic response according to RECIST (p = 0.021 and p = 0.010, respectively).

Conclusion: Pre-treatment LDH and hemoglobin are strong independent predictors of survival in HR-STS patients. Systemic inflammatory indices based on circulating immune cells may not serve as reliable prognostic factors for HR-STS patients undergoing curative-intent treatment. Higher pre-treatment albumin levels and lower CRP values may reflect a reduced inflammatory status and could be associated with a poorer radiologic response to preoperative treatment.

Dokument bearbeiten Dokument bearbeiten